New outreach aims to close smoking cessation gap for BIPOC communities

NCT ID NCT05671380

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a proactive, culturally tailored outreach program to help BIPOC adults who smoke quit tobacco. Researchers will enroll 700 participants from two health systems and provide personalized materials and support to connect them with proven cessation treatments. The goal is to see if this approach increases quit rates and reduces tobacco-related heart disease disparities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Longitudinal Proactive Outreach (behavioral intervention)
What this could lead to
If successful, this approach could provide an effective, scalable way to help BIPOC smokers quit, reducing tobacco-related heart disease in these communities.
What could go wrong
This is a pragmatic trial testing a behavioral intervention, not a new drug or cure. Success depends on participants' engagement, and results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder nicotine dependence Smoking Smoking Cessation Tobacco Use Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hennepin Healthcare

    Minneapolis, Minnesota, 55415, United States

  • Mayo Clinic Health System

    Rochester, Minnesota, 55902, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.